AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Glimozen-MP1 Tablet ER

Prescription Icon
Prescription Required

Marketer

Brzee Mediscience

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)

Overview Glimozen-MP1 Tablet ER

Metformin-glimepiride extended-release tablets manage blood glucose levels in adults with type 2 diabetes. This medication, used alongside diet and exercise, enhances insulin effectiveness, reducing blood sugar. Follow your doctor's prescribed dosage and regimen; take with food to prevent digestive discomfort. If a dose is missed, take it promptly unless the next dose is imminent; avoid doubling up. Overdosage risks dangerously low blood sugar. Concurrent use with other diabetes medications, alcohol, or skipped meals may cause hypoglycemia; regular blood glucose monitoring is crucial. Potential side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Patients with kidney, liver, or heart conditions, or those pregnant or breastfeeding, must consult their physician before use. Kidney function will be assessed prior to treatment initiation. Limit alcohol consumption to minimize adverse reactions.

Uses of Glimozen-MP1 Tablet ER

Managing type 2 diabetes

Major Benefits of Glimozen-MP1 Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimozen-MP1 Tablet ER whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

Common Side effects of Glimozen-MP1 Tablet ER:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Nausea
  • Diarrhea
  • Dizziness
  • Vomiting
  • Anemia (low number of red blood cells)
  • Weakness
  • Sinus infection

How to use Glimozen-MP1 Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glimozen-MP1 Tablet ER. Ingest the tablet whole; do not crush, chew, or divide it. Administer this medication with food.

How Glimozen-MP1 Tablet ER works:

Glimozen-MP1 Extended-Release tablets combine the actions of three distinct antidiabetic agents: glimepiride, metformin, and pioglitazone. This triple combination offers enhanced blood sugar management when single or dual-drug regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts by reducing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Finally, pioglitazone, a thiazolidinedione, further enhances the body's sensitivity to insulin.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimozen-MP1 Tablet ER and alcohol is strongly discouraged due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Glimozen-MP1 tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Glimozen-MP1 tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimozen-MP1 Tablet ER cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Glimozen-MP1 Tablet ER use. Physician consultation is recommended. Regular kidney function monitoring is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimozen-MP1 Tablet ER cautiously, potentially requiring dosage modification. Consult a physician. Glimozen-MP1 Tablet ER is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glimozen-MP1 Tablet ER :

Should you forget a Glimozen-MP1 Tablet ER dose, take it immediately. However, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimozen-MP1 Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimozen-MP1 Tablet ER

Consuming alcohol while taking Glimozen-MP1 Tablet ER is unsafe. Alcohol can cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Tell your doctor before taking Glimozen-MP1 Tablet ER if you have congestive heart failure, kidney or liver problems, or swelling behind your eye. Also inform your doctor if you are pregnant, breastfeeding, or premenopausal, and about all medications you're taking, including prescription and over-the-counter drugs, vitamins, and herbal supplements.
Metformin, a component of Glimozen-MP1 Tablet ER, can lead to vitamin B12 deficiency with prolonged use due to impaired intestinal absorption.
Glimozen-MP1 Tablet ER can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial, and carrying a quick-sugar source, such as candy or chocolate, is recommended.
Store this medication in its original, tightly closed container, as directed on the packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimozen-MP1 Tablet ER
90
MRP 110
18% off